United States News All stories

Textron Aviation Defense, a subsidiary of Textron (NYSE:TXT), has been awarded a five-year U.S. government contract valued at more than $150 million.

Diana Shipping (NYSE:DSX) escalated its hostile takeover bid for Genco Shipping & Trading (NYSE:GNK) on Monday, sending a letter to shareholders to nominate six independent director candidates.

BiomX (NYSE:PHGE) announced on April 13, 2026, that it has accelerated the exercise of an exclusive option to acquire a controlling interest in DFSL, an Israeli-based defense engineering firm.

Genmab (NASDAQ:GMAB) presented new data at the 2026 Society of Gynecologic Oncology (SGO) Annual Meeting on Monday, demonstrating that its investigational antibody-drug conjugate (ADC), rinatabart sesutecan (Rina-S), can be safely combined with bevacizumab in patients with advanced ovarian cancer.

RedCloud Holdings (NASDAQ:RCT), a pioneer in intelligent infrastructure for global trade, has entered into a five-year licensing agreement valued at up to $30 million to deploy its RAID (Realtime AI for Distribution) engine across the Kingdom of Saudi Arabia.

Revolution Medicines (NASDAQ:RVMD) shares jumped 36% in pre-market trading Monday after the company reported positive topline results from its global Phase 3 RASolute 302 study.

CVRx (NASDAQ:CVRX), a commercial-stage medical device company specializing in neuromodulation for cardiovascular disease, reported on April 13, 2026, preliminary revenue growth of approximately 20% for the first quarter.

ALT5 Sigma (NASDAQ:ALTS), a leading provider of blockchain-powered payment and settlement infrastructure, reported its financial results for the fiscal year ended December 27, 2025, today.

Sify Technologies (NASDAQ:SIFY), a leader in India's digital ICT space, reported on April 13, 2026, a 13% increase in consolidated revenue for the fiscal year ended March 31, 2026.

Voyager Technologies (NYSE:VOYG) announced on April 13, 2026, that it has successfully doubled the production capacity at its Denver-metro facility over the past year.

Collins Aerospace, a subsidiary of RTX (NYSE:RTX), has been awarded multiple contracts by Bell Textron to supply five mission-critical systems for the U.S. Army’s MV-75 Future Long Range Assault Aircraft (FLRAA).

Xtant Medical Holdings (NYSE:XTNT) announced on April 13, 2026, that it has secured exclusive U.S. distribution rights for HEMOBLAST Bellows, a specialized hemostatic powder developed by Dilon Technologies.

Kymera Therapeutics (NASDAQ:KYMR) received U.S. Food and Drug Administration Fast Track designation for its experimental treatment for moderate-to-severe eosinophilic asthma, a move that could accelerate the path to market for the first-in-class oral therapy.

Aeluma (NASDAQ:ALMU), a pioneer in the development of high-performance optoelectronic devices, announced on April 13, 2026, that it has been awarded more than $4 million in new U.S. government contracts.

Perella Weinberg Partners (NASDAQ:PWP) has entered into a definitive agreement to acquire Gleacher Shacklock, a prominent London-based independent advisory firm.

Lazard (NYSE:LAZ) reported preliminary assets under management (AUM) of approximately $259.2 billion as of March 31, 2026.

Eli Lilly and Company (NYSE:LLY) announced Monday that its Phase 3 BRUIN CLL-322 trial achieved its primary endpoint, demonstrating that the addition of Jaypirca (pirtobrutinib) to a standard regimen of venetoclax and rituximab significantly extended the time patients lived without their disease worsening.

Somnigroup International (NYSE:SGI) reached an agreement to acquire Leggett & Platt (NYSE:LEG) in an all-stock transaction valued at approximately $2.5 billion, a move that unites the world's largest bedding brand owner with its primary component supplier.

Fastenal (NASDAQ:FAST), a global leader in the wholesale distribution of industrial and construction supplies, reported its financial results for the first quarter ended March 31, 2026, today.

Vertiv Holdings (NYSE:VRT), a global provider of critical digital infrastructure and continuity solutions, announced on April 13, 2026, the acquisition of BMarko Structures.

Regeneron Pharmaceuticals (NASDAQ:REGN) and Telix Pharmaceuticals (NASDAQ:TLX) announced a landmark strategic collaboration on April 13, 2026, to co-develop and co-commercialize next-generation radiopharmaceutical therapies (RPTs).

Hillman Solutions (NASDAQ:HLMN), a leading provider of hardware products and merchandising solutions, announced on April 13, 2026, the acquisition of Delaney Hardware.

Allogene Therapeutics (NASDAQ:ALLO), a pioneer in allogeneic "off-the-shelf" CAR-T cell therapy, announced promising interim futility results today from its randomized Phase 2 ALPHA3 trial.

Regeneron Pharmaceuticals (NASDAQ:REGN) and Sanofi (NASDAQ:SNY) announced on April 13, 2026, that the European Commission, has expanded the marketing authorization for Dupixent (dupilumab) to include children aged 2 to 11 years with moderate-to-severe chronic spontaneous urticaria (CSU).